HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vidya P Ramamurthy Selected Research

3- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- diene

10/2019Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo.
8/2017Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice.
9/2015Galeterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vidya P Ramamurthy Research Topics

Disease

8Prostatic Neoplasms (Prostate Cancer)
10/2019 - 02/2015
7Neoplasms (Cancer)
10/2019 - 01/2014
3Neoplasm Metastasis (Metastasis)
03/2019 - 05/2017
2Triple Negative Breast Neoplasms
03/2019 - 01/2014
2Breast Neoplasms (Breast Cancer)
07/2014 - 01/2014
1Disease Progression
08/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2017
1Carcinogenesis
05/2017

Drug/Important Bio-Agent (IBA)

6Eukaryotic Initiation Factor-4EIBA
03/2019 - 01/2014
33- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- dieneIBA
10/2019 - 09/2015
3Phosphotransferases (Kinase)IBA
03/2019 - 02/2015
3Androgen Receptors (Androgen Receptor)IBA
01/2018 - 02/2015
3Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2014
2Therapeutic UsesIBA
10/2019 - 01/2018
2Mitogen-Activated Protein KinasesIBA
03/2019 - 01/2018
2Peptide Initiation Factors (Initiation Factor)IBA
05/2017 - 01/2014
1Pharmaceutical PreparationsIBA
10/2019
1enzalutamideIBA
10/2019
1ChemokinesIBA
03/2019
14- (+;- )- (1H- imidazole- 1- yl)- N- (4- fluorophenyl)- (E)- retinamideIBA
03/2019
1Mechanistic Target of Rapamycin Complex 1IBA
03/2019
1CytokinesIBA
03/2019
1Prostate-Specific Antigen (Semenogelase)IBA
01/2018
1VimentinIBA
01/2018
1Cadherins (E-Cadherin)IBA
01/2018
1Dihydrotachysterol (AT 10)IBA
01/2018
1Cyclin D1IBA
01/2018
1Matrix Metalloproteinases (MMPs)IBA
01/2018
1retinamideIBA
01/2018
1CateninsIBA
01/2018
1ClaudinsIBA
01/2018
1GemcitabineFDA Link
08/2017
1AndrogensIBA
01/2017
1Ether (Diethyl Ether)IBA
07/2016
1Cytochromes c (Cytochrome c)IBA
09/2015
1VNPT55IBA
09/2015
1Letrozole (Femara)FDA LinkGeneric
07/2014
1Aromatase (CYP19)IBA
07/2014
1Aromatase InhibitorsIBA
07/2014
1ThapsigarginIBA
07/2014
14-(1H-imidazol-1-yl)retinoic acidIBA
07/2014

Therapy/Procedure

4Castration
10/2019 - 09/2015
4Therapeutics
03/2019 - 01/2014